Abstract-Activation of the renin-angiotensin (Ang)-aldosterone system is involved in the pathology of vascular diseases.
R upture of cerebral artery aneurysms results in catastrophic subarachnoid hemorrhage and a high risk for morbidity and mortality. 1 On the basis of epidemiological data showing a high incidence of cerebral aneurysms in postmenopausal women, we subjected female rats to increased hemodynamic stress, hypertension, and estrogen deficiency (by oophorectomy); in these animals, the incidence of cerebral aneurysms was high. 2 Treatment with 17␤-estradiol or an angiotensin (Ang) II type 1 receptor blocker reduced this incidence. 2 Elsewhere we suggested that endothelial injury is an initial event in the pathogenesis of cerebral aneurysms and that an increase in Ang II and NADPH oxidase subunits is involved. 2 Also, inflammation and degradation of the extracellular matrix in the vascular wall play a role in the development of cerebral aneurysms. [3] [4] [5] The renin-Ang-aldosterone system is involved in the pathophysiology of cardiovascular and kidney diseases, activation of the mineralocorticoid receptor (MR) is especially highlighted in recent studies. 6 -10 The identification of a new site of MR expression in nonepithelial tissues, such as the heart, 11 vasculature, 12 and brain, 13 suggested the presence in these tissues of potential new MR target genes with unexpected biological functions. In aortic endothelial cells, aldosterone increased the expression of Ang-converting enzyme (ACE) genes that may be involved in the development of vascular injury. 14 Eplerenone, a selective MR antagonist, performs beneficial actions, such as antihypertensive, antiinflammatory effects, 15 the prevention of cardiac fibrosis, 16 and the suppression of NADPH oxidase activity 8, 15 and matrix metalloproteinase (MMP). 17 However, the relationship between MR and cerebral aneurysms remains unclear.
We show that, in female rats, MR blockade by eplerenone inhibited the progression of cerebral aneurysms via its antioxidant and anti-inflammatory effects, suppressed local renin-Ang system (RAS) activation, and decreased their salt intake in a blood pressure-independent manner. We also demonstrate that MR activation by the MR agonist deoxycorticosterone acetate (DOCA) contributed to the formation of cerebral aneurysms.
Materials and Methods
For detailed descriptions of Materials and Methods, please see the online Data Supplement at http://hyper.ahajournals.org.
Results

MR Blockade Suppresses the Progression of Experimentally Induced Cerebral Aneurysms
Based on our morphological findings, we classified the left anterior cerebral artery-olfactory artery (ACA-OA) bifurca-tion as normal, as exhibiting endothelial damage, and as manifesting cerebral aneurysm ( Figure S1 in the online Data Supplement). As shown in Figure 1A , 59% of the vehicle controls (VC) developed cerebral aneurysms at the left ACA-OA bifurcation. The rate of aneurysm development in eplerenone-treated rats (30 mg/kg per day, Epl-30 group; 100 mg/kg per day, Epl-100 group) was reduced in a dosedependent manner (27% in Epl-30, P value not significant; 9.1% in Epl-100 versus VC, PϽ0.05), and the average aneurysm size was significantly reduced in the Epl-100 group (PϽ0.05; Figure 1B ), suggesting that MR blockade contributed to the suppression of cerebral aneurysms.
There was no significant difference in the systolic blood pressure (SBP) between eplerenone-treated and VC rats ( Figure 1C ). The saline intake of Epl-100 was significantly lower than of VC rats ( Figure 1D ), and the plasma aldosterone level was significantly higher in eplerenone-treated than VC rats ( Figure S2 ).
MR Blockade Reduces Oxidative Stress and Inflammatory Reaction in the Cerebral Vascular Wall
Next, we investigated the molecular mechanisms of cerebral aneurysm formation and the effect of MR blockade. Immunohistochemically, the levels of nitrotyrosine, NOX4, and Rac1 representing an oxidative stress index were higher in the endothelium of cerebral aneurysms than in sham-operated rats ( Figure 2A) ; eplerenone reduced their expression levels. In VC rats, macrophages were primarily located in the aneurysmal wall ( Figure 2B ). The area per 150ϫ150 m that contained macrophages was smaller in eplerenone-treated than VC rats (PϽ0.05; Figure 2C ). Monocyte chemoattractant protein 1 (MCP-1) and MMP-9, as proinflammatory molecules, were abundantly expressed in the aneurysmal wall ( Figure 2B ). Their expression was low in eplerenone-treated rats and almost undetectable in sham-operated rats. The mRNA levels of NOX4, Rac1, MCP-1, and MMP-9 were significantly higher in VC-than in sham-operated rats ( Figure  3A through 3D); they were reduced by eplerenone (PϽ0.05).
Immunohistochemical staining of cerebral arteries from VC rats demonstrated MR expression in the endothelium and smooth muscle cells of aneurysms and parent arteries ( Figure S3A ). We detected the MR gene in cerebral arteries from VC rats by quantitative real-time PCR ( Figure S3B ). Eplerenone reduced the protein and mRNA level of MR ( Figure S3A and S3B).
MR Blockade Reduces Activation of the Local RAS in the Cerebral Vascular Wall
We examined the effect of MR blockade on the local RAS in cerebral aneurysms. Immunohistochemically, Ang II was highly expressed in the endothelium ( Figure 2B) ; eplerenone reduced its expression.
ACE1 and ACE2 regulate the Ang II levels. 18 The mRNA level of ACE1 was significantly higher in VC rats than sham-operated rats ( Figure 3E) ; it was significantly decreased by eplerenone (PϽ0.05). The mRNA level of ACE2 was not different among the 3 groups ( Figure 3F ), suggesting that MR blockade partly reduced the activation of the local RAS in the aneurysmal wall via the downregulation of ACE1. We hypothesized that oxidative stress, inflammation, activation of the local RAS, and saline intake via MR activation are associated with cerebral aneurysms.
DOCA Salt Induces Cerebral Aneurysms Despite a Moderate Blood Pressure Increase
To test whether the activation of MR contributes to cerebral aneurysm formation, we used DOCA, an MR agonist, instead of inducing renal hypertension (rHT) by ligation. The incidence of cerebral aneurysms in DOCA rats was similar to that in rHT rats (69% versus 59%; Figure 4A ). The aneurysm size was not different between the 2 groups ( Figure 4B ). SBP in DOCA rats was moderately elevated compared with shamoperated rats, and it was lower than in rHT rats (PϽ0.05; Figure 4C ). The saline intake of DOCA rats was significantly increased ( Figure 4D ) compared with that of rHT rats. The plasma aldosterone level was significantly lower in DOCA rats than in sham-operated rats ( Figure S4 ); plasma aldosterone was not different between DOCA and rHT rats. Based on our observation that, in DOCA rats, the incidence of cerebral aneurysms was almost the same as in rHT rats, we posit that MR activation is involved in the pathogenesis of cerebral aneurysms.
MR Activation Induces the Upregulation of Molecules Related to Oxidative Stress, Inflammation, and the Local RAS in the Aneurysmal Wall
We examined whether oxidative stress, inflammation, and the local RAS contribute to the pathogenesis of cerebral aneurysms in DOCA rats. The mRNA levels of NOX4, p22phox, MCP-1, and MMP-9 were significantly higher in DOCA rats than in sham-operated rats ( Figure 5A through 5D); the ACE1 mRNA level was also higher in DOCA rats ( Figure  5E ). On the other hand, the level of ACE2 mRNA was lower in DOCA rats than in sham-operated rats ( Figure 5F ).
Discussion
We report 2 new insights. First, blockade of MR activation by eplerenone suppressed the formation of cerebral aneurysms in rats. Second, the inhibition mechanisms may involve attenuation of oxidative stress and vascular inflammation, as well as inhibition of the activation of the local RAS. The reduced salt intake of rats subjected to MR blockade may be associated with the lower incidence of cerebral aneurysms.
Human studies have shown a link between elevated plasma aldosterone and stroke risk, especially the risk for hemorrhagic stroke. 19, 20 A comparison of patients with essential hypertension and primary hyperaldosteronism suggested that the increased incidence of cerebral hemorrhage in the latter group is blood pressure-independent. 21 In stroke-prone spontaneously hypertensive rats fed a high-salt diet, MR antagonists prevented spontaneous hemorrhagic stroke without lowering the blood pressure. 22, 23 Moreover, autosomal-dominant polycystic kidney disease was strongly associated with the development of cerebral aneurysms; these patients exhibited significantly higher plasma aldosterone concentrations in the supine and upright positions and after ACE inhibition. 24 These studies imply that aldosterone or MR activation is linked to hemorrhagic stroke or cerebral aneurysm development.
Estrogen deficiency induced reactive oxygen species generation and endothelial damage leading to cerebral aneurysm formation; in combination with hypertension, their effects were enhanced. 2 Here we demonstrate that the protein and gene expression of NADPH oxidase subunits was increased in parallel with the increased expression of nitrotyrosine in the aneurysmal wall. We also found that inflammatory molecules and macrophage infiltration were increased in the aneurysmal wall. MCP-1 is a major factor promoting the accumulation of macrophages in atherosclerosis 25 and abdominal aortic aneurysms, 26 and it is involved in the patho- We demonstrated that MR activation with DOCA resulted in a high incidence of cerebral aneurysms, and the mRNA levels of oxidative stress and inflammatory genes were increased despite a moderate increase in blood pressure. Oxidative stress and inflammation are associated with RAS activation. 27 We found that Ang II production was increased in the aneurysm wall and that the mRNA level of ACE1 was increased in rHT and DOCA rats. MR blockade reduced the production of Ang II and the mRNA level of ACE1. Our results suggest that MR activation partly induced (and that MR blockade partly reduced) local RAS activation.
rHT is related to the activation of systemic RAS. In the DOCA-salt model, hypertension is generated by plasma volume expansion secondary to an increased sodium load and is associated with a dramatic reduction of plasma renin and Ang II concentrations. 28 In preliminary studies, plasma renin activity was one tenth lower in DOCA rats than in rHT rats (data now shown), suggesting that the SBP response to DOCA is listless compared with the response in the presence of rHT. Although it had no marked effect on blood pressure, MR blockade reduced the incidence of aneurysmal changes and suppressed increases in the aneurysmal size. Therefore, the mechanisms underlying the suppression of cerebral aneurysm development would be independent of the antihypertensive effect of MR blockade.
MR blockade did not normalize the expression of genes, suggesting that the residual elevation of genes may be attributable to the increased blood pressure. We do not know what portion of the increase in gene expression is attributable Cross-talk between MR activation and estrogen deficiency may be an important factor in promoting oxidative stress and the inflammatory state 29 and may lead to the formation of cerebral aneurysms. A synergistic relationship between salt-induced and MRmediated tissue injury has been suggested 30, 31 ; salt-loading enhanced reactive oxygen species generation and MR activation in target tissues. 31 In an ecological analysis of the correlation between urinary sodium excretion and stroke mortality in Western Europe, the relationship between 24-hour urinary sodium excretion and stroke mortality was much stronger than between blood pressure and stroke mortality. 32 Zhang et al 33 showed that the formation of cerebral aneurysms in stroke-prone spontaneously hypertensive rat was significantly increased by sodium loading. In our rats subjected to MR blockade, the saline intake was reduced, whereas in rats with DOCA-induced MR activation, it was increased significantly in parallel with an increase in the incidence of cerebral aneurysms. In previous studies, treatment with MR antagonists increased or did not affect urinary sodium excretion. 22, 34, 35 Thunhorst et al 36 showed that DOCA treatment progressively increased sodium ingestion, and the sodium intake exceeded the urinary sodium excretion; they suggested that the mechanisms underlying these effects involve actions on the brain that affect the central binding of Ang II and mineralocorticoid. Furthermore, Titze et al 37 showed that DOCA-salt led to a total-body sodium excess. Our and other findings suggest that MR activation increases sodium retention and that high sodium retention may have additive harmful effects on the formation of cerebral aneurysms.
Rigsby et al 38 and Dorrance et al 39 indicated that MR blockade by spironolactone reduced the cerebral infarction size in male stroke-prone spontaneously hypertensive rats, and MR activation with DOCA increased the size of cerebral infarcts; they suggested that MR activation results in inward hypertrophic remodeling of the cerebral vasculature and an increase in infarct size. However, cerebral aneurysms involve outward remodeling, and the vascular aneurysmal wall tends to be thin rather than thick. Moreover, cerebral aneurysms commonly arise at the arterial bifurcation where abnormal hemodynamic stress affects the vascular wall 40 ; this may contribute to the differences in the reported results.
Perspectives
We first demonstrated that, in female rats, MR blockade reduced the incidence of cerebral aneurysm formation concomitant with a decrease in oxidative stress, inflammation, and the local RAS and that MR activation plays an important role in the formation of cerebral aneurysms. There are some limitations in our study. Because we did not use aged rats, our results do not reflect the possible effects of ageing. MR blockade was not sufficiently strong to completely prevent aneurysmal growth. Because the development of cerebral aneurysms involves multiple factors, other pathogenic mechanisms must be investigated. It remains unclear whether MR activation is associated with the rupture of cerebral aneurysms, because there are no reliable animal models of subarachnoid hemorrhage as a consequence of aneurysmal rupture. In future studies, we need to establish a reliable experimental subarachnoid hemorrhage model and investigate the efficacy of MR blockade in preventing subarachnoid hemorrhage.
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Materials and Methods
Induction of experimental cerebral aneurysms
Cerebral aneurysms were induced as described by Jamous et al. 1 
Treatment regimens
Treatment 1: MR antagonist
Immediately after the ligation of the right CCA and the posterior branches of both renal arteries, the rats received eplerenone (30 mg/kg/day, Epl-30 group; 100 mg/kg/day, Epl-100 group) or vehicle (0.5% methylcellulose; VC group) in their food for 3 months. Eplerenone was kindly supplied by Pfizer Inc. (New York, NY).
Treatment 2: DOCA
We subjected 7-week-old female rats to ligation of the right CCA and at the same time we subcutaneously implanted 90-day-release pellets containing 200 mg deoxycorticosterone acetate (DOCA) (Innovative Research of America, Sarasota, FL)
instead of performing renal artery ligation. One week later their drinking water was substituted with a 1.0% saline solution and one month post-ligation they underwent bilateral OVX. Two months after OVX they were euthanized as described above and samples for vascular corrosion casts and for the determination of aneurysmal mRNA were prepared.
Preparation and study of vascular corrosion casts
Vascular corrosion casts of control-(n=17), Epl-30-(n=11), Epl-100-(n=11), and DOCA rats (n=13) were prepared by transcardial infusion with Boston No. 17 plastic (Polyscience Inc., Warrington, PA). 2 As our previous studies 1, 2 had indicated that cerebral aneurysms tended to be induced preferentially at the left anterior cerebral artery -olfactory artery (ACA-OA) bifurcation, this site was inspected at 3 kV under a scanning electron microscope (SEM) (VE8800, Keyence, Osaka, Japan). Based on our morphological findings we classified the left ACA-OA bifurcation as normal, indicating that there is neither arterial dilation nor are there irregular cell shapes, as exhibiting endothelial damage, indicating that the endothelial surface was rough and irregular without marked luminal dilation, and as harboring a cerebral aneurysm evidenced by changes such as moderate outward evagination or an obvious saccular aneurysm ( Figure   S1 ). To determine the aneurysmal size, 3 blinded readers manually outlined regions of interest corresponding to areas with aneurysmal involvement on each image using National Institutes of Health (Bethesda, MD) ImageJ software.
Measurement of plasma aldosterone levels and saline intake
Twelve weeks after renal ligation the rats were anesthetized; plasma samples were preserved at -80C until use. The plasma aldosterone concentration was measured by radioimmunoassay using an aldosterone RIA kit II (SRL, Tokyo, Japan). To examine the relationship between saline intake and aneurysm formation and mineralocorticoid receptor (MR), the saline intake in the course of 24 hr was recorded weekly throughout the study period.
Immunohistochemistry and cell counting
Sham-operated-(n=15), VC-(n=15), and Epl-100 rats (n=13) were used for immunohistochemical study. At 12 weeks after renal ligation, the rats were deeply 
RNA isolation and quantitative RT-PCR
Samples from sham-operated-(n=7), VC-(n=7), Epl-100-(n=7), and DOCA rats (n=6), were subjected to quantitative real-time PCR (qRT-PCR). At 12 weeks after OVX, the rats were euthanized as described above. The left ACA-OA bifurcation was isolated and total RNA was extracted using the EZ1 RNA Universal Tissue Kit (QIAGEN, Fluorescence measurements were taken at the end of the annealing phase. FastStart DNA master plus SYBR Green  (Roche) was used for ACE2. The primers were 5'-cagacgtatgggtgagtgat-3'/5'-ggtggcttaagtgttgggta-3'. The PCR conditions were 95C for 10 min followed by 50 cycles at 95C for 10 sec, 60C for 10 sec, and 72C for 8 sec. We subjected samples from each group of rats to 2 independent qRT-PCR assays.
GAPDH was the internal control.
Statistical analysis
Data (mean ± SD) were analyzed with the Mann-Whitney U test for 2-group comparisons and analysis of variance (ANOVA) followed by Scheffe's test for multiple comparisons. The incidence of cerebral aneurysmal changes was analyzed with the Fisher exact test. P values of < 0.05 were considered to indicate statistical significance. . Plasma aldosterone levels determined by radioimmunoassay using an aldosterone RIA kit II in vehicle-control (VC)-and eplerenone-treated rats (30 mg/kg/day, Epl-30; 100 mg/kg/day, Epl-100) (each group n=7). Eplerenone significantly increased the plasma aldosterone level. Data (mean ± SD) were analyzed by one-way ANOVA followed by Scheffe's test. †p < 0.01 vs VC. Epl indicates eplerenone; VC, vehicle control. Plasma aldosterone levels in sham-operated-(sham), renal hypertensive-(rHT), and DOCA rats (each group=7). The plasma aldosterone level was significantly lower in DOCA-than sham rats. Data (mean ± SD) were analyzed by one-way ANOVA followed by Scheffe's test: *p < 0.05 vs sham.
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